COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States

The coronavirus disease 2019 (COVID-19) has affected more than 29 million people and led to more than 542,000 deaths in the United States.(1) Older age, comorbidities, and racial and ethnic minority status are associated with severe COVID-19.(2) Among patients with inflammatory bowel disease (IBD),...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Manasi, Brenner, Erica J., Yan Mak, Joyce Wing, Zhang, Xian, Kaplan, Gilaad G., Ng, Siew C., Reinisch, Walter, Steinwurz, Flavio, Lewis, James D., Kissous-Hunt, Michele, Modesto, Irene, Ungaro, Ryan C., Colombel, Jean-Frederic, Kappelman, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169727/
https://www.ncbi.nlm.nih.gov/pubmed/34089848
http://dx.doi.org/10.1016/j.cgh.2021.05.060
Descripción
Sumario:The coronavirus disease 2019 (COVID-19) has affected more than 29 million people and led to more than 542,000 deaths in the United States.(1) Older age, comorbidities, and racial and ethnic minority status are associated with severe COVID-19.(2) Among patients with inflammatory bowel disease (IBD), racial and ethnic minorities have worse outcomes, mediated in part by inequitable health care access.(3) Racial and ethnic minority patients with IBD and COVID-19 may be an especially vulnerable population. The purpose of this study was to evaluate racial and ethnic disparities in COVID-19 outcomes among IBD patients and the impact of non-IBD comorbidities on observed disparities.

Ejemplares similares